Background & Aims Hepatitis E virus (HEV) infection can cause chronic hepatitis in recipients
of solid organ transplants. However, the factors that contribute to chronic infection and the …

Background There is no established therapy for hepatitis E virus (HEV) infection. The aim of
this retrospective, multicenter case series was to assess the effects of ribavirin as …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing coronavirus
disease 2019 (COVID-19), was reported for the first time in Wuhan (Hubei Province, …

Fulminant hepatitis is a severe complication of hepatitis A virus infection. Its mechanism is
unknown. Liver transplantation can be necessary, but spontaneous recovery is frequent. …

Long‐term immunoprophylaxis with hepatitis B immune globulin (HBIG) is widely accepted
for the prevention of recurrent hepatitis B virus (HBV) infection after liver transplantation in …

Background & Aims Protease inhibitors (PI) with peginterferon/ribavirin have significantly
improved SVR rates in HCV G1 patients. Their use to treat HCV recurrence after liver …

Liver transplantation in patients coinfected with human immunodeficiency virus (HIV) and
hepatitis C virus (HCV) is a recent indication. In a single center, we have compared the survival …

Objective Antibody response to the messenger RNA (mRNA) COVID‐19 vaccine has been
shown to be diminished in rituximab (RTX)–treated patients. We undertook this study to …

Between 1 June 2016 and 31 May 2017, 17 European Union (EU) and European Economic
Area countries reported 4,096 cases associated with a multi-country hepatitis A (HA) …

Background Human enteric viruses are resistant in the environment and transmitted via the
faecal-oral route. Viral shedding in wastewater gives the opportunity to track emerging …